Beckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Department of Oral and Maxillofacial Surgery/Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Curr Oncol. 2023 Jan 11;30(1):1046-1053. doi: 10.3390/curroncol30010080.
Late detection and specialist referral result in poor oral cancer outcomes globally. High-risk LRMU populations usually do not have access to oral medicine specialists, a specialty of dentistry, whose expertise includes the identification, treatment, and management of oral cancers. To overcome this access barrier, there is an urgent need for novel, low-cost tele-health approaches to expand specialist access to low-resource, remote and underserved individuals. The goal of this study was to compare the diagnostic accuracy of remote versus in-person specialist visits using a novel, low-cost telehealth platform consisting of a smartphone-based, remote intraoral camera and custom software application. A total of 189 subjects with suspicious oral lesions requiring biopsy (per the standard of care) were recruited and consented. Each subject was examined, and risk factors were recorded twice: once by an on-site specialist, and again by an offsite specialist. A novel, low-cost, smartphone-based intraoral camera paired with a custom software application were utilized to perform synchronous remote video/still imaging and risk factor assessment by the off-site specialist. Biopsies were performed at a later date following specialist recommendations. The study's results indicated that on-site specialist diagnosis showed high sensitivity (94%) and moderate specificity (72%) when compared to histological diagnosis, which did not significantly differ from the accuracy of remote specialist telediagnosis (sensitivity: 95%; specificity: 84%). These preliminary findings suggest that remote specialist visits utilizing a novel, low-cost, smartphone-based telehealth tool may improve specialist access for low-resource, remote and underserved individuals with suspicious oral lesions.
全球范围内,口腔癌的晚期发现和专科转诊导致了不良的治疗结果。高危 LRMU 人群通常无法接触到口腔医学专家,该专家的专长包括识别、治疗和管理口腔癌。为了克服这种就诊障碍,迫切需要新颖的、低成本的远程医疗方法,以扩大资源有限、偏远和服务不足人群对专科医生的访问。本研究的目的是使用一种新颖的、低成本的远程医疗平台(包括基于智能手机的远程口腔内摄像头和定制软件应用程序)来比较远程与现场专科就诊的诊断准确性。共招募了 189 名需要活检的疑似口腔病变患者(根据标准护理)并获得其同意。每位患者均接受了两次检查,记录了两次风险因素:一次由现场专家,另一次由远程专家。使用新型低成本智能手机式口腔内摄像头与定制软件应用程序,远程专家可进行同步远程视频/静态成像和风险因素评估。根据专家建议,随后在稍后日期进行活检。研究结果表明,与组织学诊断相比,现场专家诊断的敏感性(94%)高,特异性(72%)适中,与远程专家远程诊断的准确性无显著差异(敏感性:95%;特异性:84%)。这些初步结果表明,利用新颖的、低成本的、基于智能手机的远程医疗工具进行远程专家就诊可能会改善资源有限、偏远和服务不足的疑似口腔病变患者的专科医生就诊机会。